The Street, Galore, MarketWatch, and MSN Provide Coverage of Our Role in the CBD Industry

CBD-infused beauty products, medical marijuana in Mexico, and a new non-cannabis source of CBD lead Medical Marijuana, Inc.’s headlines for the week.

Once again, Medical Marijuana, Inc. and our portfolio of cannabis companies were featured in stories from across the internet. Find the biggest stories from our family of companies below.

CBD and Beauty Products

Kannaway’s Cannabis Beauty Defined anti-aging skincare line was included in a trio of articles this week looking at CBD as a popular ingredient in beauty products.

Kannaway CEO Blake Schroeder was interviewed this week by The Street in an article focusing on the use of CBD in beauty products and the sudden boom in this sector of the CBD industry.

The article, titled “Bath Bombs and Muscle Creams: How Beauty Is Becoming the Fast Lane for Cannabis Growth”, explored how the enormous beauty industry has taken hold of CBD as its most exciting new ingredients.

“[Beauty] went from something we didn’t talk about at all at in the company to this becoming a significant part of our sales,” says Schroeder in the interview with The Street’s Real Money. “As we continue to expand, this is a product that we can lead with that’s going to have less regulatory issues than other cannabis-based products.”

Galore Magazine also looked at CBD in skincare this week. The article looked at five products from the CBD-infused Cannabis Beauty Defined Line, reviewing each product and revealing its benefits with daily use. The product line was also reviewed on Splinter.

You can find the Cannabis Beauty Defined product line now in the Medical Marijuana, Inc. store.

Medical Marijuana in Mexico

Medical Marijuana, In. subsidiary HempMeds® Mexico was featured as part of coverage of the country’s medical marijuana program on La Calle TV. The story explored the role of HempMeds® Mexico in the recent legalization of medical cannabis in Mexico.

HempMeds® President, Latin America, Raul Elizalde was part of the initial push for access to THC-free CBD products, the first cannabis products legally permitted for medicinal use for a Mexican citizen. This first case was Elizalde’s daughter Grace, and the Mexican government approved product imported for her was RSHO-X™, our first-of-its-kind THC-free CBD product.

According to the article, “The medical marijuana market in Mexico has 11.4 million patients and offers a potential of 2,000 million dollars for the next 10 years.” This is a market that Medical Marijuana, Inc. was first into, helping to expand access to cannabis products to those that need them.

Find more about HempMeds® Mexico here.

New Non-Cannabis CBD Product Reviewed

Medical Marijuana, Inc.’s innovative new non-cannabis CBD product, RSHO-K™, was reviewed this week on My Beauty Bunny alongside other CBD products. The article thoroughly explored CBD, its effects, and its status in the U.S. It also revealed the significance of RSHO-K™ as a source of CBD that isn’t cannabis, opening access to new markets and freeing users from exposure to even trace levels of THC.

Investing in Medical Marijuana, Inc.

This week, several investing and finance sites took a look at the opportunity to invest in Medical Marijuana, Inc. The Pot Network, focusing on marijuana companies trading as penny stocks, compared them to companies like Ford, Pier 1 Imports, and SiriusXM, which all also started as penny stocks before growing into large corporations.

A Benzinga article also looked at the potential in investing in the cannabis industry, including Medical Marijuana, Inc. among other big cannabis companies in the cannabis space. The article, which was picked up by MarketWatch and MSN, also featured a quote from Medical Marijuana, Inc.

“The robust investment banking group involved with the IPO signals greater acceptance by the investing community of nationally licensed cannabis operations,” said Medical Marijuana’s Titus. “Certainly, the progressive attitudes in Canada about cannabis are creating tremendous value for the licensed and legitimate enterprises. By contrast, in the US, we see no such investor interest in American companies, as they are only allowed to participate at the state level and remain federally ‘questionable.’ Thus, America continues to prevent expansion and growth of the industry and will likely lose top talent to Canadian entrepreneurs as ‘money talks.’”

Read More

You can find more updates from the Medical Marijuana, Inc. family of companies, including coverage in media outlets, on our news feed.

The post The Street, Galore, MarketWatch, and MSN Provide Coverage of Our Role in the CBD Industry appeared first on Medical Marijuana, Inc..

Go to OG News Source
Author: Jeffrey Stamberger